[go: up one dir, main page]

Washburn et al., 2006 - Google Patents

A novel three‐dose regimen of daclizumab in liver transplant recipients with hepatitis C: a pharmacokinetic and pharmacodynamic study

Washburn et al., 2006

View PDF @Full View
Document ID
561365764126522942
Author
Washburn W
Teperman L
Heffron T
Douglas D
Gay S
Katz E
Klintmalm G
Publication year
Publication venue
Liver transplantation

External Links

Snippet

This study evaluated the pharmacokinetics and pharmacodynamics of a novel 3‐dose regimen of daclizumab in de novo hepatitis C liver transplant recipients. In 30 of 156 recipients receiving daclizumab, mycophenolate mofetil, tacrolimus, and no steroids (Arm 3 …
Continue reading at aasldpubs.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
US11982670B2 (en) Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
Zhang et al. Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction
Jucaud et al. Prevalence and impact of de novo donor‐specific antibodies during a multicenter immunosuppression withdrawal trial in adult liver transplant recipients
Okochi et al. Observations on Australia antigen in Japanese
Hauser et al. Natural killer cell activity in multiple sclerosis.
Gorbacheva et al. Memory CD4 T cells induce antibody-mediated rejection of renal allografts
JP6728047B2 (en) Treatment methods and compositions
Honda et al. De novo membranous nephropathy and antibody‐mediated rejection in transplanted kidney
RU2679913C2 (en) Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction
US20130028890A1 (en) Method for detecting regulatory t cells using expression of folate receptor 4 as indicator, method for treating diseases using the detection method, pharmaceutical composition for immunostimulation, and method for treating diseases using the composition
JP2005106694A (en) Early detection and severity assessment of sepsis
Salah et al. Application of complement component 4d immunohistochemistry to ABO‐compatible and ABO‐incompatible liver transplantation
Lankisch et al. Antinuclear and pancreatic acinar cell antibodies in pancreatic diseases
Boleslawski et al. CD28 expression by peripheral blood lymphocytes as a potential predictor of the development of de novo malignancies in long‐term survivors after liver transplantation
Citterio et al. C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients
Wasi et al. Serum-immunoglobulin levels in thalassaemia and the effects of splenectomy
EP2538217A1 (en) Method of identifying risk for thyroid disorder
Utsumi et al. Risk analysis for invasive fungal infection after living donor liver transplantation: which patient needs potent prophylaxis?
Washburn et al. A novel three‐dose regimen of daclizumab in liver transplant recipients with hepatitis C: a pharmacokinetic and pharmacodynamic study
Xing et al. Calcitriol reduces the occurrence of acute cellular rejection of liver transplants: A prospective controlled study
CN120129835A (en) Diagnosis of immune-mediated inflammatory diseases using MMP12 as an indicator, and therapeutic drugs for immune-mediated inflammatory diseases based on inhibition of MMP12
Mizokami et al. Human T-lymphotropic virus type I-associated uveitis in patients with Graves' disease treated with methylmercaptoimidazole
Adams et al. Biliary β2-microglobulin in liver allograft rejection
Delaney et al. Constitutive and acquired resistance to calcineurin inhibitors in renal transplantation: role of P‐glycoprotein‐170
US20250044280A1 (en) Methods for diagnosing or predicting a cardiac inflammatory condition